Dr Karen Mosley is the CRF General Manager at the NIHR/Wellcome Trust Imperial Clinical Research Facility. She is primarily responsible for the business, financial and regulatory aspects of the CRF providing operational leadership and management.
Dr Mosley was awarded a PhD in Biochemistry in 1998 from the Institute of Neurology, University of London and worked as a researcher in the Renal Department at Imperial College London from 1994-2008.
et al., 2006, Urinary proteomic profiles distinguish between active and inactive lupus nephritis, Rheumatology, Vol:45, ISSN:1462-0324, Pages:1497-1504
et al., 2004, Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy, Blood, Vol:104, ISSN:0006-4971, Pages:2714-2721
et al., 2004, Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy, Gene Therapy, Vol:11, ISSN:0969-7128, Pages:1117-1125
et al., 2003, Regulation by CD25(+) lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease, Kidney International, Vol:64, ISSN:0085-2538, Pages:1685-1694
et al., 2005, Urinary proteomic profiles are able to discriminate between active and inactive lupus nephritis, The American Society of Nephrology